Dmytro Kharkov

Nautilus Biotechnology accelerates with Voyager Platform launch and first customer announcements

Nautilus Biotechnology accelerates with Voyager Platform launch and first customer announcements
Nautilus Biotechnology launches Voyager Platform

Nautilus Biotechnology has rolled out the Nautilus Voyager Platform, a major step for the company in recent months.

In addition to the platform launch, Nautilus Biotechnology has initiated its Iterative Mapping Early Access Program and named its first customers. These developments signal a period of rapid growth and activity as the company advances its ambition to transform proteomics research. Details about the new offerings were shared in a company blog post.

Nautilus Biotechnology recently appointed Amber Faust as Vice President of Sales to support commercial growth in proteomics, according to a company announcement. The company also featured US HUPO President-Elect Olga Vitek in a recent episode focused on statistics in proteomics. These moves precede the current launch of the Voyager Platform and the Early Access Program.

This material may contain third-party opinions, none of the data and information on this webpage constitutes investment advice according to our Disclaimer. While we adhere to strict Editorial Integrity, this post may contain references to products from our partners.
Weekly Top Bonuses
up to $2,500
deposit bonus for all clients
CLAIM BONUS
Your capital is at risk.